Astellas Pharma (Astellas Pharma) Pretax Margin % : 4.10% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Astellas Pharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Astellas Pharma's Pre-Tax Income for the three months ended in Dec. 2023 was $120 Mil. Astellas Pharma's Revenue for the three months ended in Dec. 2023 was $2,930 Mil. Therefore, Astellas Pharma's pretax margin for the quarter that ended in Dec. 2023 was 4.10%.

The historical rank and industry rank for Astellas Pharma's Pretax Margin % or its related term are showing as below:

ALPMY' s Pretax Margin % Range Over the Past 10 Years
Min: 1.4 Med: 15.99 Max: 21.48
Current: 1.4

ALPMY's Pretax Margin % is ranked worse than
57.93% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 4.555 vs ALPMY: 1.40

Astellas Pharma Pretax Margin % Historical Data

The historical data trend for Astellas Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Pretax Margin % Chart

Astellas Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Pretax Margin %

Get a 7-Day Free Trial

19.06

18.86

11.63

12.10

8.72

Astellas Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pretax Margin %	Get a 7-Day Free Trial															14.86	-13.51	12.49	1.36	4.10

Competitive Comparison of Astellas Pharma's Pretax Margin %

For the Drug Manufacturers - General subindustry, Astellas Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's Pretax Margin % falls into.

Astellas Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Astellas Pharma's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	990.249	/	11361.441
	=	8.72 %

Astellas Pharma's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	120.245	/	2930.46
	=	4.10 %

Astellas Pharma (OTCPK:ALPMY) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Astellas Pharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (Astellas Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMY) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.